Alzheimer’s disease is characterized by extracellular beta amyloid (Aβ) plaques (A), intraneuronal tau tangles (T), and neurodegeneration (N), referred to as the A/T/N framework for AD biomarker classification [29,30]. The gene discussed is MAPT; the disease is early-onset autosomal dominant Alzheimer disease.